Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small amount of bleeding at the injection site after a Wegovy shot is common and almost always harmless. Most people see a tiny drop of blood or a faint red spot where the needle entered the skin — this typically stops within a minute and leaves no lasting mark. It is not a sign that something has gone wrong. That said, it helps to know what normal looks like, and when a different reaction deserves a closer look. Wegovy (semaglutide) is a prescription-only medicine; a GPhC-registered prescriber assesses clinical suitability before it is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The skin is threaded with tiny capillaries. When a pen needle passes through, it occasionally clips one of these small vessels. The result is a pinprick of blood on the surface, not a wound, just a normal consequence of breaking the skin. Most people barely notice it. A clean cotton pad or tissue pressed gently for thirty seconds is all that's needed; resist the urge to rub, which can extend a bruise under the surface.
Injection angle and speed also play a part. Wegovy's pre-filled pen is designed to be used at a 90-degree angle to the skin. Pinching the skin lightly before injecting can lift the subcutaneous fat layer clear of underlying muscle, a technique the Patient Information Leaflet describes. Jabbing too quickly or hesitating mid-injection both increase the chance of nicking a vessel. With practice, most people find injection-site bleeding becomes rarer.
One misconception worth naming: some people assume that blood in the needle tip means the medicine was injected into a vein and is therefore unsafe. In reality, the needle is far too short to reach a vein, and a drop of capillary blood at the surface poses no risk to the dose or your health. The full Wegovy guide explains how the medicine is absorbed subcutaneously rather than intravascularly.
Once bleeding has stopped, a small bruise sometimes develops over the following hour or two. This is simply blood that leaked from the capillary spreading into the surrounding tissue. It is tender to the touch, fades through yellow and green over a week or so, and requires nothing beyond patience. Cold compression applied briefly in the first ten minutes can reduce how large a bruise spreads, wrap an ice pack in a cloth rather than applying it directly to skin.
Alongside bruising, the injection site may show mild redness, itching or a small raised area. These reactions are listed in the NHS semaglutide medicines page as known local effects, generally mild and self-limiting. They do not indicate an allergy unless they spread beyond the immediate site, worsen significantly, or come with hives, facial swelling or breathing difficulty, those symptoms need urgent medical attention.
Rotating your injection site each week is the single most effective way to prevent repeated trauma to the same tissue. Approved sites are the abdomen (avoid the area around the navel), the front of the thigh, and the upper outer arm. More on managing the days immediately after an injection can be found on the day after your Wegovy shot page.
Heavier or longer-lasting bleeding is uncommon but deserves attention. If steady bleeding does not settle with firm, sustained pressure within five minutes, contact a healthcare professional. People taking blood-thinning medicines (such as warfarin or direct oral anticoagulants) may find any injection-site bleeding is slower to stop; if you take these medicines, your prescriber should already be aware and may have given specific advice.
A lump that feels warm, grows larger over days, or becomes increasingly painful may signal a small haematoma (a pocket of collected blood) or, more rarely, an infection. Both are worth a clinical assessment. The lump after a Wegovy shot page covers what these formations typically look like and how they are managed.
Heavy unexplained bruising across multiple sites, or bleeding that seems disproportionate to the injection, is something to raise with your GP or prescriber promptly. It may have nothing to do with Wegovy and more to do with an underlying clotting factor, but a prescriber is the right person to work through that, not a forum. You can also report unexpected side effects to the MHRA directly at the MHRA Yellow Card scheme.
Technique matters more than most people realise. These four points, drawn from standard injection guidance, make a measurable difference.
First, let the pen reach room temperature before injecting. A cold semaglutide pen can increase injection discomfort and the likelihood of a site reaction. Second, change the needle with every single injection. Reused needles develop microscopic barbs that cause more tissue trauma even when the damage is invisible. Third, avoid injecting into areas with visible veins, active bruising, or broken skin. Fourth, after removing the needle, apply gentle pressure with a dry pad and hold it, rather than wiping across the site.
If bleeding or bruising is a persistent concern affecting your confidence with the injections, that is a reasonable thing to raise with your prescriber at your next review. Persistent site reactions are also covered on the bleeding from a Wegovy shot page if you want more detail on what classifies as a reaction worth escalating. For a broader look at what semaglutide is and how it works, the semaglutide overview is a good starting point. And if you have questions about cost or how private treatment is structured, the Wegovy pricing page sets out what the private market currently looks like. Wegovy is a prescription-only medicine requiring clinical assessment; if you are thinking about starting treatment, a free consultation with our prescribers is the first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.